Riveria Investment Group Makes Minority Investment in Yaqrit Discovery Ltd.

July 8, 2020

Riveria Investment Group has made a minority growth investment in Yaqrit Discovery Ltd., a clinical-stage liver disease biotechnology company spun out of University College London. The funding will support Yaqrit's ongoing clinical programs targeting cirrhosis and Acute-on-Chronic Liver Failure (ACLF) and its broader development plans for complications of cirrhosis including NASH and NAFLD.

Buyers
Riveria Investment Group
Targets
Yaqrit Discovery Ltd.
Industry
Biotechnology
Location
England, United Kingdom
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.